KDR and neoplasm: In 2011, Hao et al. [24] evaluated the potential of the dimeric peptoid GU40C4 labeled with positron emitter 64Cu to be used for tumor visualization in a prostate cancer mouse model highly expressing VEGFR2, exploiting the relatively small size of the molecule, the high in vivo stability and binding affinity to the receptor.